Alexander Zukiwski
Chief Tech/Sci/R&D Officer at CASI PHARMACEUTICALS, INC.
Network origin in Alexander Zukiwski first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD.
26
| Subsidiary | Biotechnology | 26 |
| Public Company | Pharmaceuticals: Major | 10 | |
Oncolyze, Inc.
 Oncolyze, Inc. BiotechnologyHealth Technology Oncolyze, Inc. is a private company developing a novel technology for cancer treatment. The company is based in New York, NY and was founded by Steven J. Evans and John H. Abeles. The company's lead drug candidate targets the cancer cell membrane and selectively kills cancer cells and cancer stem cells while sparing normal cells, potentially providing a highly effective treatment with little to no side effects. The initial therapeutic target is acute myeloid leukemia (AML), a cancer with a low five-year survival rate. Oncolyze's drug has been shown to destroy leukemic cancer stem cells, disrupting current medical treatment. Steven J. Evans has been the CEO since incorporation.
5
| Private Company | Biotechnology | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Alexander Zukiwski via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Sales & Marketing | |
| INTEL CORPORATION | Semiconductors | Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | President Director/Board Member | |
| NOVAVAX, INC. | Biotechnology | Director/Board Member Chairman President Corporate Officer/Principal Director of Finance/CFO Sales & Marketing | |
MedImmune Ltd.
 MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Chief Executive Officer Director/Board Member | |
MedImmune Ventures, Inc.
 MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland. | Investment Managers | Founder Private Equity Investor Private Equity Investor | |
Pulmatrix Operating Co., Inc.
 Pulmatrix Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Pulmatrix Operating Co., Inc. develops pharmaceutical products for respiratory infectious diseases. Its iSPERSE powders can be used with an array of dry powder inhaler technologies and can be formulated with virtually any drug substance. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov and Robert S. Langer in 2003 and is headquartered in Lexington, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| MERSANA THERAPEUTICS, INC. | Biotechnology | Chairman Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Omthera Pharmaceuticals, Inc.
 Omthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Omthera Pharmaceuticals, Inc. operates as pharmaceuticals company which focuses on the clinical development of new therapies for dyslipidemia. The company was founded by Jerry Wisler and Michael Davidson in 2008 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| NEXIMMUNE, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Corbus Pharmaceuticals, Inc.
 Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
SCILEX Pharmaceuticals, Inc.
 SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | Pharmaceuticals: Major | Director/Board Member | |
| University of Virginia | College/University | Undergraduate Degree Undergraduate Degree | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Doctorate Degree Doctorate Degree | |
NEA Management Co. LLC
 NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
| VCANBIO CELL & GENE ENGINEERING CORP., LTD | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| The Johns Hopkins University | College/University | Director/Board Member Graduate Degree | |
| University of Iowa | College/University | Doctorate Degree Undergraduate Degree | |
| University of Kentucky | College/University | Undergraduate Degree | |
| University of Maryland | College/University | Graduate Degree Doctorate Degree | |
| Villanova University | College/University | Undergraduate Degree Undergraduate Degree | |
| The University of Sydney | College/University | Undergraduate Degree | |
| EMERGENT BIOSOLUTIONS INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Baylor College of Medicine | College/University | Doctorate Degree Doctorate Degree | |
| Renmin University of China | College/University | Masters Business Admin Graduate Degree | |
Virginia Biotechnology Association
 Virginia Biotechnology Association Miscellaneous Commercial ServicesCommercial Services Virginia Biotechnology Association promotes the biotechnology industry. The private company is based in Richmond, VA. The company was founded in 1992 by Terry R. Woodworth. John L. Newby has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Director/Board Member | |
| SAGIMET BIOSCIENCES INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chairman Director/Board Member | |
| ARDELYX, INC. | Pharmaceuticals: Major | Chairman Chief Operating Officer | |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The private company is based in Wilmington, DE. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| University of Maryland School of Medicine | College/University | Corporate Officer/Principal | |
AstraZeneca Thailand Ltd.
 AstraZeneca Thailand Ltd. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca Thailand Ltd. operates as a science-led biopharmaceutical company. The private company is based in Bangkok, Thailand. | Pharmaceuticals: Major | President | |
Complexa, Inc.
 Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
Biohealth Innovation, Inc.
 Biohealth Innovation, Inc. Financial ConglomeratesFinance Biohealth Innovation, Inc. sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth. It is a regional innovation intermediary that accelerates and facilitates technology transfer and commercialization of market-relevant research in federal labs, universities, and biohealth companies in the Region. The company was founded in 2011 and is headquartered in Rockville, MD. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| Perelman School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Chongqing TCR CURE Biopharma Technology Co., Ltd
 Chongqing TCR CURE Biopharma Technology Co., Ltd Pharmaceuticals: MajorHealth Technology Chongqing TCR CURE Biopharma Technology Co., Ltd is a company that develops immunotherapy for T cell cancer. The company is based in Chongqing, China. and has subsidiaries in China. The Chinese company was founded in 2016 by Wei-Wu He, Zhen Bo Su, Qi-Jing Li, Pin Wang. Qi-Jing Li has been the CEO since 2016. | Pharmaceuticals: Major | Founder Founder | |
Affinia Therapeutics, Inc.
 Affinia Therapeutics, Inc. BiotechnologyHealth Technology Affinia Therapeutics, Inc. is a preclinical stage company, which engages in the research and development of gene therapy. It offers Affinia Rationally-designed Therapies (ART) platform, which develops novel therapies, focusing on the key components of a gene therapy: capsids, which are the outer shells of a virus used to package the genetic code to treat a disease; promoters, which control how the cells read the genetic code that is delivered; and manufacturing approaches, which determine the quality and cost of potential medicines. The company was founded by Luk Vandenberghe, Botond Roska, and Aaron Tward in 2019 and is headquartered in Waltham, MA. | Biotechnology | Director/Board Member Chief Executive Officer | |
Vtesse, Inc.
 Vtesse, Inc. BiotechnologyHealth Technology Vtesse, Inc. provides novel drugs for life-threatening rare diseases. It developed VTS-270, a modified form of cyclodextrin that has been evaluated in preclinical and clinical studies at institutes within the National Institutes of Health (NIH) to treat patients with Niemann-Pick Disease Type C (NPC). The firm is working with the NIH and other leading academic centers to advance clinical study of VTS-270 for NPC, and to conduct pre-clinical discovery and development of other novel drugs for NPC and other LSDs. The company was founded by Ben Machielse in 2015 and is headquartered in Gaithersburg, MD. | Biotechnology | Chairman Corporate Officer/Principal | |
| University of Illinois At Urbana–Champaign | College/University | Graduate Degree | |
| SCILEX HOLDING COMPANY | Pharmaceuticals: Other | Director/Board Member |
Statistics
International
| United States | 41 |
| China | 4 |
| United Kingdom | 3 |
| Japan | 2 |
| Thailand | 2 |
Sectoral
| Health Technology | 26 |
| Consumer Services | 15 |
| Commercial Services | 5 |
| Finance | 4 |
| Electronic Technology | 2 |
Operational
| Director/Board Member | 164 |
| Corporate Officer/Principal | 99 |
| Independent Dir/Board Member | 47 |
| Chairman | 37 |
| Undergraduate Degree | 34 |
Most connected contacts
| Insiders | |
|---|---|
| Ed Mathers Mathers | 47 |
| David Mott | 45 |
| John H. Abeles | 33 |
| Rosemary Mazanet | 24 |
| Wei Wu He | 19 |
| Yue Wu | 16 |
| James Young | 15 |
| Gerald McMahon | 13 |
| James L. Foght | 13 |
| Zheng Bin Yao | 11 |
| Néstor A. Molfino | 10 |
| Xue Bo Zeng | 10 |
| Mark E. Spring | 10 |
| Barbara White | 10 |
| Ravichandran Rao | 10 |
- Stock Market
- Insiders
- Alexander Zukiwski
- Company connections
